Paul Bycott

Paul Bycott is the Executive Director of Breast Cancer & Oncology Early Clinical Development Statistics at Pfizer, a position they have held since 2023. With extensive experience in statistics, Paul previously served in various roles at Pfizer, including Senior Statistician II, Director, and Senior Director before becoming Executive Director. Additionally, Paul worked as a Senior Statistician I at Parke-Davis and a Biostatistician II at Amgen. Paul completed their education at UCLA from 1990 to 1997.